Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation.

W Y Au1, A K W Lie, A W C Kung

  • 1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong. auwing@hotmail.com

Bone Marrow Transplantation
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome.

Blood cancer journal·2016
Same author

Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.

Neuroscience·2016
Same author

Serum calcium and incident diabetes: an observational study and meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Cost-effective osteoporosis intervention thresholds for Hong Kong postmenopausal women.

Hong Kong medical journal = Xianggang yi xue za zhi·2015
Same author

Topography Influences Adherent Cell Regulation of Osteoclastogenesis.

Journal of dental research·2015
Same author

Three-dimensional charge density wave order in YBa2Cu3O6.67 at high magnetic fields.

Science (New York, N.Y.)·2015
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same journal

A multimodal sexual health intervention among hematopoietic stem cell transplant recipients: mediating effects on quality of life and mood.

Bone marrow transplantation·2026
Same journal

Excellent clinical and patient-reported outcomes following matched sibling donor BMT for sickle cell disease.

Bone marrow transplantation·2026
See all related articles

Autoimmune thyroid disease (AITD) can occur after hematopoietic stem cell transplantation (HSCT). Female donors and specific HLA DR9 alleles are significant risk factors, necessitating careful monitoring of susceptible patients.

Area of Science:

  • Immunology
  • Hematology
  • Endocrinology

Background:

  • Autoimmune thyroid disease (AITD) is a potential complication following hematopoietic stem cell transplantation (HSCT).
  • Understanding risk factors for AITD post-HSCT is crucial for patient management.

Purpose of the Study:

  • To investigate the incidence and risk factors of AITD in patients undergoing HSCT.
  • To identify specific genetic (HLA) and donor-related factors associated with AITD development.

Main Methods:

  • Retrospective analysis of 721 HSCT recipients, identifying 10 cases of AITD.
  • Statistical analysis to determine significant risk factors, including HLA loci and donor characteristics.
  • Review of existing literature on AITD post-HSCT.

Related Experiment Videos

Main Results:

  • The 5-year actuarial AITD rates were 2.9% after allogeneic and 4% after autologous HSCT.
  • Significant risk factors identified were HSCT for chronic myeloid leukemia, HLA B46 and DR9 loci, and the A2B46DR9 haplotype.
  • Multivariate analysis confirmed female donors and HLA DR9 as significant predictors; HLA associations were also significant in autologous HSCT.

Conclusions:

  • Female donors and specific HLA alleles (DR9) are significant risk factors for AITD after HSCT.
  • The actuarial incidence of AITD in susceptible recipients may exceed 30%, warranting close monitoring.
  • Further data from larger registries are needed to confirm these findings and refine risk stratification.